BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27045029)

  • 21. Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and Hypertension.
    Chen D; Stegbauer J; Sparks MA; Kohan D; Griffiths R; Herrera M; Gurley SB; Coffman TM
    Hypertension; 2016 Jun; 67(6):1291-7. PubMed ID: 27141055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney.
    Irita J; Okura T; Jotoku M; Nagao T; Enomoto D; Kurata M; Desilva VR; Miyoshi K; Matsui Y; Uede T; Denhardt DT; Rittiling SR; Higaki J
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F833-44. PubMed ID: 21734100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial Mineralocorticoid Receptors Differentially Contribute to Coronary and Mesenteric Vascular Function Without Modulating Blood Pressure.
    Mueller KB; Bender SB; Hong K; Yang Y; Aronovitz M; Jaisser F; Hill MA; Jaffe IZ
    Hypertension; 2015 Nov; 66(5):988-97. PubMed ID: 26351033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.
    Kagiyama S; Matsumura K; Fukuhara M; Sakagami K; Fujii K; Iida M
    Hypertens Res; 2007 Oct; 30(10):979-89. PubMed ID: 18049031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stretch-activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries.
    Schleifenbaum J; Kassmann M; Szijártó IA; Hercule HC; Tano JY; Weinert S; Heidenreich M; Pathan AR; Anistan YM; Alenina N; Rusch NJ; Bader M; Jentsch TJ; Gollasch M
    Circ Res; 2014 Jul; 115(2):263-72. PubMed ID: 24838176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling.
    Di Zhang A; Nguyen Dinh Cat A; Soukaseum C; Escoubet B; Cherfa A; Messaoudi S; Delcayre C; Samuel JL; Jaisser F
    Hypertension; 2008 Dec; 52(6):1060-7. PubMed ID: 18981328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial Sodium Channel in Aldosterone-Induced Endothelium Stiffness and Aortic Dysfunction.
    Jia G; Habibi J; Aroor AR; Hill MA; Yang Y; Whaley-Connell A; Jaisser F; Sowers JR
    Hypertension; 2018 Sep; 72(3):731-738. PubMed ID: 29987101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
    Iglarz M; Touyz RM; Viel EC; Amiri F; Schiffrin EL
    Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin.
    Verlander JW; Hong S; Pech V; Bailey JL; Agazatian D; Matthews SW; Coffman TM; Le T; Inagami T; Whitehill FM; Weiner ID; Farley DB; Kim YH; Wall SM
    Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1314-25. PubMed ID: 21921024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T regulatory lymphocytes prevent aldosterone-induced vascular injury.
    Kasal DA; Barhoumi T; Li MW; Yamamoto N; Zdanovich E; Rehman A; Neves MF; Laurant P; Paradis P; Schiffrin EL
    Hypertension; 2012 Feb; 59(2):324-30. PubMed ID: 22146512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal Mineralocorticoid Receptor Contributes to Epithelial Sodium Channel-Mediated Intestinal Sodium Absorption and Blood Pressure Regulation.
    Nakamura T; Kurihara I; Kobayashi S; Yokota K; Murai-Takeda A; Mitsuishi Y; Morisaki M; Kohata N; Oshima Y; Minami Y; Shibata H; Itoh H
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29929989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension.
    Hernanz R; Martínez-Revelles S; Palacios R; Martín A; Cachofeiro V; Aguado A; García-Redondo L; Barrús MT; de Batista PR; Briones AM; Salaices M; Alonso MJ
    Br J Pharmacol; 2015 Jun; 172(12):3159-76. PubMed ID: 25712370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
    Brassard P; Amiri F; Schiffrin EL
    Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
    Luther JM; Gainer JV; Murphey LJ; Yu C; Vaughan DE; Morrow JD; Brown NJ
    Hypertension; 2006 Dec; 48(6):1050-7. PubMed ID: 17043157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
    Chrissobolis S
    Curr Hypertens Rev; 2017; 13(1):46-56. PubMed ID: 28245785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
    Takayanagi T; Kawai T; Forrester SJ; Obama T; Tsuji T; Fukuda Y; Elliott KJ; Tilley DG; Davisson RL; Park JY; Eguchi S
    Hypertension; 2015 Jun; 65(6):1349-55. PubMed ID: 25916723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.